Radial Access Data in Vascular Interventions Registry

NCT07614386 | Recruiting

• 1 other identifier: SRL-RADIUS-001
• Study Type: observational
• Target: 20,000
• Locations: 1 country
• Sites: 1

Brief Summary

The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access. Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed. The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned. This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.

Conditions

Radial Artery Occlusion; Radial Artery Spasm; Vascular Access Complications; Coronary Artery Disease; Peripheral Arterial Disease

Keywords

Radial access; Ulnar access; Transradial intervention; Coronary angiography; Percutaneous coronary intervention; Vascular complications; Radial artery occlusion; Radial Artery Spasm; Registry

Outcome Measures

Primary Outcomes (3)

• Radial Artery Occlusion Rate

  Incidence of radial artery occlusion following percutaneous vascular interventions performed via radial artery access.

  Within 1 year after procedure

• Access-Site Vascular Complication Rate

  Incidence of vascular access-site complications including bleeding, hematoma, pseudoaneurysm, arterial dissection, and vascular injury.

  through study completion, an average of 1 year

• Radial Artery Spasm Rate

  Incidence of clinically significant radial artery spasm during or immediately after the procedure.

  During Procedure

Secondary Outcomes (6)

• Procedural Success Rate

  During procedure

• Crossover Rate

  During Procedure

• Bleeding Complications

  During Procedure

• Fluoroscopy Time

  During Procedure

• Length of Hospital Stay

  From the date of vascular intervention until hospital discharge, assessed up to 30 days

Study Arms (1)

Radial and Ulnar Access Registry Cohort

Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.

Procedure: Radial and Ulnar Artery Access

Interventions

Radial and Ulnar Artery Access PROCEDURE

Routine percutaneous vascular interventions performed via radial or ulnar artery access according to standard clinical practice.

Radial and Ulnar Access Registry Cohort

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Adult patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access.

You may qualify if:

• Age ≥18 years
• Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access
• Ability to provide informed consent

You may not qualify if:

• Age \<18 years
• Procedures performed without radial or ulnar artery access
• Incomplete procedural or clinical data
• Refusal to participate in the registry

Sponsors & Collaborators

• Mersin Medicalpark Hastanesi: lead

Study Sites (1)

Mersin Medicalpark hospital

Mersin, Mezitli, 33010, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Arterial Occlusive Diseases; Coronary Artery Disease; Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases; Coronary Disease; Myocardial Ischemia; Heart Diseases; Arteriosclerosis; Atherosclerosis; Peripheral Vascular Diseases

Study Officials

• Sefa SURAL, MD

  Toros University

  STUDY DIRECTOR

Central Study Contacts

Sefa SURAL, MD

CONTACT

+90 532 565 01 60; sesural@hotmail.com

Gökhan AVCI, MD

CONTACT

+90 506 228 57 09; drgavci@hotmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Year
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 15, 2026
• First Posted: May 29, 2026
• Study Start: May 15, 2026
• Primary Completion (Estimated): December 31, 2030
• Study Completion (Estimated): May 20, 2031
• Last Updated: June 1, 2026

Record last verified: 2026-05

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)